UnitedHealth Group (NYSE:UNH) updated its FY19 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of approach $15 for the period, compared to the Thomson Reuters consensus estimate of $14.83. The company issued revenue guidance of ~$242 billion, compared to the consensus revenue estimate of $242.73 billion.UnitedHealth Group also updated its FY20 guidance to $16.25-16.55 EPS.
Shares of NYSE UNH opened at $279.66 on Tuesday. The company has a market capitalization of $265.15 billion, a PE ratio of 21.71, a PEG ratio of 1.48 and a beta of 0.64. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.67. The stock’s 50 day moving average price is $258.05 and its 200-day moving average price is $245.34. UnitedHealth Group has a twelve month low of $208.07 and a twelve month high of $287.94.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $3.88 EPS for the quarter, beating the Zacks’ consensus estimate of $3.75 by $0.13. The company had revenue of $60.35 billion during the quarter, compared to the consensus estimate of $59.84 billion. UnitedHealth Group had a return on equity of 25.30% and a net margin of 5.57%. UnitedHealth Group’s revenue was up 6.7% on a year-over-year basis. During the same period last year, the business posted $3.41 earnings per share. As a group, research analysts expect that UnitedHealth Group will post 14.96 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be given a $1.08 dividend. The ex-dividend date is Friday, December 6th. This represents a $4.32 annualized dividend and a yield of 1.54%. UnitedHealth Group’s dividend payout ratio is currently 33.54%.
A number of brokerages have issued reports on UNH. ValuEngine upgraded UnitedHealth Group from a sell rating to a hold rating in a research note on Wednesday, October 2nd. Morgan Stanley reiterated a buy rating and set a $312.00 target price (up from $294.00) on shares of UnitedHealth Group in a research note on Friday, November 22nd. Citigroup cut their price target on shares of UnitedHealth Group from $299.00 to $286.00 and set a buy rating on the stock in a report on Wednesday, October 16th. SunTrust Banks reiterated a buy rating and issued a $335.00 price objective (up previously from $310.00) on shares of UnitedHealth Group in a research note on Monday, November 18th. Finally, Barclays increased their price target on UnitedHealth Group from $260.00 to $305.00 and gave the stock an overweight rating in a research note on Monday. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. The stock presently has a consensus rating of Buy and an average target price of $289.39.
In other news, CAO Thomas E. Roos sold 1,177 shares of the stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $255.04, for a total value of $300,182.08. Following the transaction, the chief accounting officer now owns 21,687 shares of the company’s stock, valued at approximately $5,531,052.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction on Tuesday, September 17th. The shares were sold at an average price of $232.76, for a total transaction of $581,900.00. Following the sale, the director now owns 187,979 shares in the company, valued at approximately $43,753,992.04. The disclosure for this sale can be found here. Insiders have sold 38,577 shares of company stock valued at $9,398,080 in the last three months. 0.82% of the stock is owned by insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Article: Why is the LIBOR significant?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.